CN102178694B - Liquid preparation of sodium ascorbyl phosphate - Google Patents

Liquid preparation of sodium ascorbyl phosphate Download PDF

Info

Publication number
CN102178694B
CN102178694B CN 201110115702 CN201110115702A CN102178694B CN 102178694 B CN102178694 B CN 102178694B CN 201110115702 CN201110115702 CN 201110115702 CN 201110115702 A CN201110115702 A CN 201110115702A CN 102178694 B CN102178694 B CN 102178694B
Authority
CN
China
Prior art keywords
liquid preparation
antiseptic
ascorbyl phosphate
hpo
nah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110115702
Other languages
Chinese (zh)
Other versions
CN102178694A (en
Inventor
王国华
杜作宽
梅勇
刘萍
赵小萍
杨勇
万华英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Jewelland Pharmaceutical Co Ltd
Original Assignee
Sichuan Jewelland Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Jewelland Pharmaceutical Co Ltd filed Critical Sichuan Jewelland Pharmaceutical Co Ltd
Priority to CN 201110115702 priority Critical patent/CN102178694B/en
Publication of CN102178694A publication Critical patent/CN102178694A/en
Application granted granted Critical
Publication of CN102178694B publication Critical patent/CN102178694B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a liquid preparation of sodium ascorbyl phosphate. Each 1,000 milliliters of liquid preparation contains 40 to 180 grams of Na2HPO4.7H2O, 100 to 480 grams of NaH2PO4.H2O, and 0.05 to 0.3 grams of preservative. The liquid preparation of the sodium ascorbyl phosphate has a remarkable preservative effect; and the solubility, dissolution speed and stability of the sodium ascorbyl phosphate, which is the mixture of the Na2HPO4.7H2O and NaH2PO4.H2O, are high.

Description

Liquid preparation of sodium ascorbyl phosphate
Technical field
The invention belongs to field of pharmaceutical preparations, relate to a kind of Pharmaceutical composition, be specifically related to a kind of liquid preparation of sodium ascorbyl phosphate and preparation method thereof.
Background technology
Sodium ascorbyl phosphate is used for clearing up intestinal before patient's colon X-light and intestinal splanchnoscopy or the operation, sodium ascorbyl phosphate goes out non-absorbent zwitterion at the intestinal internal disintegration, in intestinal, form height and ooze environment, because the character of intestinal semipermeable membrane, make the interior moisture content of body enter intestinal, common a kind of mechanical stimulus, the promotion intestinal movement of producing of the moisture content that the moisture content that itself is contained and patient take.Sodium ascorbyl phosphate makes the interior moisture content increase of intestinal soften stool, and the local nerve that sodium ascorbyl phosphate can also activate the intestinal mucosa layer reflects and the wriggling of increase intestinal wall, improves intestinal power, promotes defecation.
Chinese patent CN200910060341.7 discloses a kind of preparation method of sodium ascorbyl phosphate oral solution, its step comprises material dissolution, boiling sterilization, filtration sterilization, boiling sterilization refers in the solution of material dissolution step gained, the adding mass volume ratio is 0.02%~0.03% sodium benzoate, after solution stirring is even, 98 ℃~100 ℃ insulations 1~2 hour; Described filtration sterilization steps is cooled to below 40 ℃ for the solution with the boiling sterilization gained, and the adding mass volume ratio is 0.10%~0.13% essence, with 0.22 μ m microporous filter membrane solution is filtered again, obtains sodium ascorbyl phosphate oral solution.The method adopts the mode of high temperature to sterilize, and equipment needed thereby and consume energy all very greatly in productions brings a lot of inconvenience to industrialization.
Summary of the invention
The purpose of this invention is to provide a kind of liquid preparation of sodium ascorbyl phosphate.
A kind of liquid preparation of sodium ascorbyl phosphate provided by the invention, the described liquid preparation of every 1000ml contains the Na of 40~180g 2HPO 47H 2O, the NaH of 100~480g 2PO 4H 2O, the antiseptic of 0.05~0.3g.
Described liquid preparation is preferably oral administration solution, contains the Na of 180g in every 1000ml oral administration solution 2HPO 47H 2O, the NaH of 480g 2PO 4H 2O, the antiseptic of 0.3g also comprises the correctives of 0.4~1g, described correctives is preferably Fructus Citri tangerinae essence, saccharin sodium, described antiseptic is preferably sodium benzoate.
Described liquid preparation is preferably enema, contains the Na of 40~100g in every 1000ml enema 2HPO 47H 2O, the NaH of 100~200g 2PO 4H 2O, the antiseptic of 0.1~0.3g, the EDTA-2Na of 0.1~0.5g, described antiseptic is preferably benzalkonium chloride.
This liquid preparation of sodium ascorbyl phosphate favorable anti-corrosion effect, sodium ascorbyl phosphate adopts Na 2HPO 47H 2O and NaH 2PO 4H 2The mixture of O, its dissolubility is good, and dissolution velocity is fast, good stability.
Another object of the present invention provides a kind of preparation method of liquid preparation of sodium ascorbyl phosphate, and the method comprises the following steps:
(1) dosing: first the antiseptic of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na 2HPO 47H 2O and NaH 2PO 4H 2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
This preparation method is simple, does not need special equipment, energy savings.
The specific embodiment
The present invention is further illustrated below in conjunction with specific embodiment, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following embodiment.All technology that realizes based on foregoing of the present invention all belong to scope of the present invention.Adjuvant in following examples can be replaced with pharmaceutically acceptable similar adjuvant, perhaps reduces, increases.
Embodiment 1
Prescription:
Figure BDA0000059514300000021
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first 2HPO 47H 2O and NaH 2PO 4H 2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 2
Prescription:
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first 2HPO 47H 2O and NaH 2PO 4H 2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 3
Prescription:
Figure BDA0000059514300000031
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first 2HPO 47H 2O and NaH 2PO 4H 2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 4
Prescription:
Figure BDA0000059514300000032
Preparation technology:
(1) dosing: first sodium benzoate, saccharin sodium, the Fructus Citri tangerinae essence of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na 2HPO 47H 2O and NaH 2PO 4H 2O, the glycerol stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Experimental example 1
Embodiment 1~embodiment 4 samples carry out limit test of microbe:
The limit test of microbe result
Figure BDA0000059514300000041
The result shows that embodiment 1~embodiment 4 sample microbial limits are up to specification, the sample favorable anti-corrosion effect.
Experimental example 2
Embodiment 1 sample carries out influence factor's test
Sample is positioned over strong illumination (4500lx ± 500), high temperature (60 ℃) condition is carried out factors influencing, detect the quality index such as its appearance character, pH value, relative density and content respectively at sampling in the 5th day, the 10th day, and compare with 0 day testing result.Also having carried out simultaneously low-temperature test (placed 2 days at 2 ℃~8 ℃ cold compartment of refrigerator first, then under 40 ℃ of conditions, accelerate to investigate 2 days, circulate three times) and freezing-thawing test (placed 2 days at-10 ℃~-20 ℃ freezer compartment of refrigerator first, then under 40 ℃ of conditions, accelerate to investigate 2 days, circulate three times), result of the test is as follows:
Influence factor's study on the stability result
By above-mentioned result of the test as can be known, this product after placing 10 days under high light, the hot conditions, each index and relatively having no significant change in 0 day.Each index that low temperature and freezing-thawing test record and 0 day are more also without significant change, without crystallization.Therefore this product is to light, heat, and low temperature etc. are all stablized, and preserves at ambient temperature to get final product.
Experimental example 3
The sodium ascorbyl phosphate dissolution velocity test of different water of crystallization
The sodium ascorbyl phosphate mixture of getting an amount of different water of crystallization (is equivalent to Na 2HPO 40.67mol and NaH 2PO 43.45mol), add water to 1000ml under the stirring condition, stir and make the principal agent dissolving, investigate the dissolution time of the sodium phosphate of different water of crystallization.The result is as follows:
The test of sodium ascorbyl phosphate dissolution velocity
Figure BDA0000059514300000052
By above-mentioned result of the test as can be known, the sodium ascorbyl phosphate mixture is by Na 2HPO 4.7H 2O and NaH 2PO 4.H 2When O forms, dissolve at normal temperatures very fastly, can obviously shorten the dissolution time that feeds intake in the technique, significantly improve production efficiency, prevent the dosing overlong time and be subjected to microbial contamination.

Claims (8)

1. a liquid preparation of sodium ascorbyl phosphate is characterized in that, the described liquid preparation of every 1000ml contains the Na of 40~180g 2HPO 47H 2O, the NaH of 100~480g 2PO 4H 2O, the antiseptic of 0.05~0.3g.
2. liquid preparation according to claim 1 is characterized in that, described liquid preparation is oral administration solution.
3. liquid preparation according to claim 2 is characterized in that, contains the Na of 180g in every 1000ml oral administration solution 2HPO 47H 2O, the NaH of 480g 2PO 4H 2O, the antiseptic of 0.3g also comprises the correctives of 0.4~1g.
4. liquid preparation according to claim 3 is characterized in that, described correctives is Fructus Citri tangerinae essence, and saccharin sodium, described antiseptic are sodium benzoate.
5. liquid preparation according to claim 1 is characterized in that, described liquid preparation is enema.
6. liquid preparation according to claim 5 is characterized in that, contains the Na of 40~100g in every 1000ml enema 2HPO 47H 2O, the NaH of 100~200g 2PO 4H 2O, the antiseptic of 0.1~0.3g, the EDTA-2Na of 0.1~0.5g.
7. liquid preparation according to claim 6 is characterized in that, described antiseptic is benzalkonium chloride.
8. the preparation method of the described liquid preparation of sodium ascorbyl phosphate of claim 1, the method comprises the following steps:
(1) dosing: first the antiseptic of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na 2HPO 47H 2O and NaH 2PO 4H 2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
CN 201110115702 2011-05-06 2011-05-06 Liquid preparation of sodium ascorbyl phosphate Active CN102178694B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110115702 CN102178694B (en) 2011-05-06 2011-05-06 Liquid preparation of sodium ascorbyl phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110115702 CN102178694B (en) 2011-05-06 2011-05-06 Liquid preparation of sodium ascorbyl phosphate

Publications (2)

Publication Number Publication Date
CN102178694A CN102178694A (en) 2011-09-14
CN102178694B true CN102178694B (en) 2013-03-20

Family

ID=44565100

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110115702 Active CN102178694B (en) 2011-05-06 2011-05-06 Liquid preparation of sodium ascorbyl phosphate

Country Status (1)

Country Link
CN (1) CN102178694B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813675A (en) * 2012-09-07 2012-12-12 天津市嵩锐医药科技有限公司 Compound potassium hydrogen phosphate medicine combination for injection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2196149T3 (en) * 1996-05-08 2003-12-16 Craig A Aronchick PURGANT PREPARATIONS NON-WATERY FOR THE COLON.
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
CN101623298B (en) * 2009-08-13 2011-09-07 成都顺道医药开发有限公司 Preparation method of sodium ascorbyl phosphate oral solution

Also Published As

Publication number Publication date
CN102178694A (en) 2011-09-14

Similar Documents

Publication Publication Date Title
CN104388416A (en) Preparation method of microporous starch embedded lactic acid bacteria
CN104323986A (en) Phloroglucinol injection and preparation method thereof
CN105193707A (en) Ambroxol hydrochloride oral solution and preparation method thereof
CN102178694B (en) Liquid preparation of sodium ascorbyl phosphate
CN102240277B (en) Pharmaceutical composition for treating periodontitis, and preparation method and application thereof
CN101829060A (en) Preparation method of clindamycin phosphate powder for injection
CN103690580B (en) The microemulsion extracting method of Herba Andrographis and extract thereof
CN105919978A (en) Preparation method of amoxicillin microsphere slow-release capsule
CN103054797A (en) Pharmaceutical composition of pantoprazole sodium and preparation method thereof
CN101912365A (en) Sulbenicillin sodium powder injection and preparation process thereof
CN104086531B (en) A kind of Esomeprazole sodium compound and its pharmaceutical composition
CN103058999A (en) Novel pantoprazole sodium compound and pharmaceutical composition thereof
CN105496942A (en) High-solubility curcumin liquid crystal preparation method
CN106177454A (en) One treats colpitic gel and preparation method thereof
CN101849916B (en) Cefpiramide sodium powder injection and preparation method thereof
CN103432067A (en) Ketoprofen solution and preparation method thereof
CN105395490B (en) A kind of freeze-dried powder of sodium pharmaceutical composition containing dextral-rabeprazole and preparation method thereof
CN103705929B (en) A kind of biocompatible microemulsion and preparation method thereof
CN104548058A (en) Application of ground beetle zymolyte
CN102150924A (en) Alliin-containing antistaling agent and production method thereof
CN102697753B (en) Roxithromycin soft capsule preparation thereof
CN102552180B (en) Clindamycin phosphate composition liensinine freeze-dried powder and preparation method thereof
CN101879145B (en) Anti-HIV drug zidovudine for injection and preparation process thereof
CN100563632C (en) A kind of injection fleroxacin and preparation method thereof
CN106967129A (en) A kind of extracting method of raffinose

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant